Developing community pharmacists’ role in the management of type 2 diabetes and related microvascular complications: a nationwide survey in Australia

Author:

Woodhams Louise1,Chalmers Leanne1ORCID,Hillis Graham S.23ORCID,Sim Tin Fei1ORCID

Affiliation:

1. Curtin Medical School, Curtin University, Perth, Western Australia, Australia

2. Medical School, The University of Western Australia, Perth, Western Australia, Australia

3. Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia

Abstract

Background Community pharmacists have regular interactions with people living with type 2 diabetes to supply medications, and have a potential role in supporting other primary care professionals in the screening, management, monitoring and facilitation of timely referral of microvascular complications. This study aimed to investigate the contemporary and future roles of community pharmacists in diabetes-related microvascular complication management. Methods This study involved an online Australian nation-wide survey of pharmacists administered via Qualtrics® and distributed through social media platforms, state and national pharmacy organisations, and via major banner groups. Descriptive analyses were undertaken using SPSS. Results Among 77 valid responses, 72% of pharmacists already provided blood pressure and blood glucose monitoring services for the management of type 2 diabetes. Only 14% reported providing specific microvascular complication services. Over 80% identified a need for a comprehensive microvascular complication monitoring and referral service, and agreed it is feasible and within the scope of practice of a pharmacist. Almost all respondents agreed that they would implement and provide a monitoring and referral service if provided with appropriate training and resources. Potential barriers to service implementation were competing demands and lack of remuneration and awareness among consumers and health professionals. Conclusions Type 2 diabetes services in Australian community pharmacies do not currently focus on microvascular complication management. There appears to be strong support for implementing a novel screening, monitoring and referral service via community pharmacy to facilitate timely access to care. Successful implementation would require additional pharmacist training, and identification of efficient pathways for service integration and remuneration.

Publisher

PeerJ

Subject

General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Reference27 articles.

1. Changes of some health indicators in patients with type 2 diabetes: a prospective study in three community pharmacies in Sharjah, United Arab Emirates;Abduelkarem;Libyan Journal of Medicine,2009

2. A systematic review of pharmacist input to metabolic syndrome screening, management and prevention;Al AdAwi;International Journal of Clinical Pharmacy,2020

3. Pharmacists 2017 factsheet;Australian Government Department of Health,2017

4. Coronavirus (COVID-19) case numbers and statistics;Australian Government Department of Health,2022

5. Improving outcomes for diverse populations disproportionately affected by diabetes: final results of project IMPACT: diabetes;Bluml;Journal of The American Pharmaceutical Association,2014

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3